← Open Payments lookup

JOHN BAUSHER: Open Payments

NPI 1033207824 · ABERDEEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$699 in 38 payments from 10 companies in 2025. Trend: 2023 $1,056 · 2024 $896 · 2025 $699

Food & beverage: $699
CompanyPaymentsAmount
Amgen Inc.15$202
GlaxoSmithKline, LLC.7$151
PFIZER INC.3$69
AstraZeneca Pharmaceuticals LP3$65
Phathom Pharmaceuticals, Inc.2$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$46
Viatris Specialty LLC2$44
Boehringer Ingelheim Pharmaceuticals, Inc.2$38
Novo Nordisk Inc1$20
Lilly USA, LLC1$18

Products named: OTEZLA, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, VOQUEZNA, XIFAXAN, YUPELRI, REPATHA.

Industry payments across WA — which companies pay providers there.